Forbes - MarketWatch - Los Angeles Times - Times Online
Sept. 29 (Bloomberg) -- Sequenom Inc.'s planned launch of a prenatal test for Down syndrome may be delayed by more than a year after a finding that research data gathered to develop the screen was mishandled.